Skip to content

Potassium lactate

BLOOD AND BLOOD FORMING ORGANS

Also known as: Potassium DL-lactate

FDA approvedATC B05XA15

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Potassium lactate is a drug catalogued in DrugCentral. It was first approved by the FDA in 1986.

  • ATC code: B05XA15 (Electrolyte solutions).
  • Molecular formula: C3H5KO3; molecular weight 128.17 g/mol.

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1986-05-08FDA—HOSPIRA

ATC classification

ATC codeTherapeutic hierarchy
B05XA15BLOOD AND BLOOD FORMING ORGANS › BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS › I.V. SOLUTION ADDITIVES › Electrolyte solutions

Chemical structure

Molecular formulaC3H5KO3
Molecular weight128.17 g/mol
CAS number996-31-6
InChIKey—
PubChem CID23671663

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

When was Potassium lactate first approved?

Potassium lactate was first approved by the FDA in 1986.

What is the chemical formula of Potassium lactate?

Potassium lactate has the molecular formula C3H5KO3 and a molecular weight of 128.17 g/mol.

Browse: all drugs starting with P · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval1986-05-08
AgencyFDA
Targets0
Indications0
FormulaC3H5KO3
DrugCentral ID4695
Interactive profile